Literature DB >> 17954222

Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins.

Charles N Serhan1, Yan Lu, Song Hong, Rong Yang.   

Abstract

Within the domain of lipidomics, lipid mediator lipidomics and informatics is an exciting area because of the important roles of lipid-derived mediators in health and disease. It is well-appreciated that arachidonic acid is a precursor to potent bioactive mediators, such as prostaglandins, leukotrienes, and lipoxins. Recent experiments employing a mediator-lipidomic approach have uncovered that other major essential polyunsaturated fatty acids, such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), serve as precursors for the production of potent bioactive mediator families, coined "resolvins" and "protectins." These omega-3 polyunsaturated fatty acids have long been noted to have beneficial effects in human systems; however, molecular evidence for their beneficial actions has been lacking and/or subject to debate. In this chapter, we review the databases and search algorithms used to identify these novel lipid mediators using liquid chromatography-ultraviolet-tandem mass spectrometry (LC-UV-MS/MS). Cognoscitive-contrast-angle algorithms and databases (COCAD) and systematic naming and empirical fragmentation rules useful in MS/MS ion identification were developed. Examples of identifying eicosanoids, resolvins, and protectins are given in human and murine tissues. The findings reviewed in this chapter demonstrate the advantages of COCAD in profiling and identification of bioactive lipid mediators and documenting activation of their biosynthetic pathways as well as in establishing relationships between lipid mediator pathways with agonists and antagonists present in the biological system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954222     DOI: 10.1016/S0076-6879(07)32012-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  22 in total

1.  Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.

Authors:  Jenny E Kanter; Farah Kramer; Shelley Barnhart; Michelle M Averill; Anuradha Vivekanandan-Giri; Thad Vickery; Lei O Li; Lev Becker; Wei Yuan; Alan Chait; Kathleen R Braun; Susan Potter-Perigo; Srinath Sanda; Thomas N Wight; Subramaniam Pennathur; Charles N Serhan; Jay W Heinecke; Rosalind A Coleman; Karin E Bornfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry.

Authors:  Zhiying Wang; Liangqiao Bian; Chenglin Mo; Maciej Kukula; Kevin A Schug; Marco Brotto
Journal:  Anal Chim Acta       Date:  2017-07-14       Impact factor: 6.558

3.  Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma.

Authors:  A M Gil-Villa; L V Norling; C N Serhan; D Cordero; M Rojas; A Cadavid
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-09-10       Impact factor: 4.006

Review 4.  Role of neutrophils in innate immunity: a systems biology-level approach.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Nov-Dec

5.  Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.

Authors:  Karen J Ho; Matthew Spite; Christopher D Owens; Hope Lancero; Alex H K Kroemer; Reena Pande; Mark A Creager; Charles N Serhan; Michael S Conte
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

6.  Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.

Authors:  Alexander J Leedom; Aaron B Sullivan; Baiyan Dong; Denise Lau; Karsten Gronert
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.

Authors:  Ana González-Périz; Raquel Horrillo; Natàlia Ferré; Karsten Gronert; Baiyan Dong; Eva Morán-Salvador; Esther Titos; Marcos Martínez-Clemente; Marta López-Parra; Vicente Arroyo; Joan Clària
Journal:  FASEB J       Date:  2009-02-11       Impact factor: 5.191

8.  Nystatin interferes with the effects of N-methyl-N'-nitro-N-nitrosoguanidine on sphingolipid metabolism in human FL cells.

Authors:  Guangyi Liu; Weimin Wang; Gongping Sun; Xiaoqiong Ma; Ziyang Liu; Jun Yang
Journal:  Lipids       Date:  2008-07-15       Impact factor: 1.880

9.  Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress.

Authors:  M Spite; L Summers; T F Porter; S Srivastava; A Bhatnagar; C N Serhan
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

10.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.

Authors:  Charles N Serhan; Rong Yang; Kimberly Martinod; Kie Kasuga; Padmini S Pillai; Timothy F Porter; Sungwhan F Oh; Matthew Spite
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.